Aortic pump devices and methods

US9839734B1 · US · B1

Patent metadata
FieldValue
Publication numberUS-9839734-B1
Application numberUS-201615367914-A
CountryUS
Kind codeB1
Filing dateDec 2, 2016
Priority dateDec 2, 2016
Publication dateDec 12, 2017
Grant dateDec 12, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A disclosed apparatus or method can include or use a non-transluminally implantantable blood pump housing, which can be sized and shaped to be implanted at an aortic valve of a human subject, the pump housing can include: a pump housing cross-sectional profile size that is larger than is passable via a blood vessel of the human subject; and a power connection, configured for being electrically connected to an intravascular lead that is sized and shaped to extend from the pump housing through a subclavian artery of the human subject.

First claim

Opening claim text (preview).

What is claimed is: 1. A method comprising: implanting a blood pump at an aortic valve or ascending aorta of a human subject, including transapically introducing the blood pump into a left ventricle of the heart of the human subject; passing a guidewire from a percutaneous access point through a subclavian artery of the human subject, through an aorta of the human subject, and into or through a left ventricle of the human subject; passing an intravascular lead, connected to the blood pump, through a subclavian artery of the human subject to receive power at the blood pump via the intravascular lead; connecting the guidewire to the intravascular lead in the left ventricle of the human subject or external to the heart or external to the human subject; and towing the blood pump, using the intravascular lead, into a location at the aortic valve or ascending aorta of the human subject. 2. The method of claim 1 , comprising connecting the blood pump to the intravascular lead before the blood pump is in the left ventricle of the heart of the human subject and before the blood pump is further introduced into the location at the aortic valve or ascending aorta of the human subject. 3. The method of claim 2 , wherein passing the intravascular lead through the subclavian artery of the human subject includes towing the blood pump into, from, or through the apex or other location of the left ventricle of the heart of the human subject into the ascending aorta of the human subject. 4. The method of claim 1 , comprising pulling the intravascular lead from the left ventricle through the subclavian artery of the human subject via a guide wire extended the opposite direction from a percutaneous access point for the subclavian artery. 5. The method of claim 1 , wherein passing the intravascular lead through the subclavian artery of the human subject is performed concurrently or after introducing the blood pump into the left ventricle of the heart of the human subject. 6. The method of claim 1 , wherein passing the intravascular lead through the subclavian artery of the human subject is performed while further introducing the blood pump into the location at the aortic valve of the subject. 7. The method of claim 6 , comprising anchoring the blood pump at an aortic valve or ascending aorta of the subject. 8. The method of claim 7 , wherein passing the intravascular lead through the subclavian artery of the human subject is performed before anchoring the blood pump at the aortic valve or ascending aorta of the subject. 9. The method of claim 7 , wherein the anchoring the blood pump at the aortic valve or ascending aorta of the subject includes expanding the anchor to secure the blood pump at the aortic valve or ascending aorta of the subject. 10. The method of claim 1 , comprising: carrying at least a portion of the intravascular lead with or attached to the blood pump while the blood pump is being introduced from the left ventricle of the heart of the human subject into the ascending aorta of the human subject. 11. The method of claim 1 , wherein implanting a blood pump comprises using a blood pump having a pump housing cross-sectional profile size that is larger than is passable via a blood vessel of the human subject. 12. The method of claim 1 , wherein implanting a blood pump comprises using a blood pump wherein the blood pump cross sectional profile is larger than 16 millimeters, and wherein the blood pump includes an axial impeller that is longitudinally arranged between a blood inlet and a blood outlet, whereby the axial impeller is sized, shaped, and otherwise configured to be capable of pumping at least 3 liters of blood per minute. 13. The method of claim 1 , wherein implanting a blood pump comprises using a blood pump wherein the blood pump cross sectional profile is larger than 20 millimeters and includes an axial impeller that is longitudinally arranged between a blood inlet and a blood outlet, whereby the axial impeller is sized, shaped, and otherwise configured to be capable of pumping at least 3 liters of blood per minute. 14. The method of claim 1 , wherein implanting a blood pump comprises using a blood pump wherein the blood pump cross sectional profile is larger than 25 millimeters and includes an axial impeller that is longitudinally arranged between a blood inlet and a blood outlet, whereby the axial impeller is sized, shaped, and otherwise configured to be capable of pumping at least 3 liters of blood per minute. 15. The method of claim 1 , comprising using the intravascular lead that is sized and shaped to extend from the pump housing, when located at the aortic valve or the ascending aorta, through the subclavian artery of the human subject to exit from the human subject. 16. A method comprising: implanting a blood pump at an aortic valve or ascending aorta of a human subject, including transapically introducing the blood pump into a left ventricle of the heart of the human subject; passing a guidewire or intravascular lead between a percutaneous access point and through a subclavian artery of the human subject, through an aorta of the human subject, and into or through a left ventricle of the human subject; and towing the blood pump, using the guidewire or the intravascular lead, into a location at the aortic valve or ascending aorta of the human subject. 17. The method of claim 16 , wherein passing a guidewire or intravascular lead comprises passing a guidewire from a percutaneous access point through a subclavian artery of the human subject, through an aorta of the human subject, and into or through a left ventricle of the human subject. 18. The method of claim 16 , comprising passing an intravascular lead, connected to the blood pump, through a subclavian artery of the human subject to receive power at the blood pump via the intravascular lead. 19. The method of claim 16 , comprising connecting the guidewire to the intravascular lead in the left ventricle of the human subject or external to the heart or external to the human subject. 20. The method of claim 16 , comprising connecting the blood pump to the intravascular lead before the blood pump is in the left ventricle of the heart of the human subject and before the blood pump is further introduced into the location at the aortic valve or ascending aorta of the human subject. 21. The method of claim 20 , wherein passing the guidewire or intravascular lead through the subclavian artery of the human subject includes towing the blood pump into, from, or through the apex or other location of the left ventricle of the heart of the human subject into the ascending aorta of the human subject. 22. The method of claim 16 , comprising pulling the intravascular lead from the left ventricle through the subclavian artery of the human subject via a guidewire extended the opposite direction from a percutaneous access point for the subclavian artery. 23. The method of claim 16 , wherein passing the guidewire or intravascular lead through the subclavian artery of the human subject is performed concurrently or after introducing the blood pump into the left ventricle of the heart of the human subject. 24. The method of claim 16 , wherein passing the guidewire or intravascular lead through the subclavian artery of the human subject is performed while further introducing the blood pump into the location at the aortic valve of the subject. 25. The method of claim 16 , comprising anch

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9839734B1 cover?
A disclosed apparatus or method can include or use a non-transluminally implantantable blood pump housing, which can be sized and shaped to be implanted at an aortic valve of a human subject, the pump housing can include: a pump housing cross-sectional profile size that is larger than is passable via a blood vessel of the human subject; and a power connection, configured for being electrically …
Who is the assignee on this patent?
Berlin Heart Gmbh
What technology area does this patent fall under?
Primary CPC classification A61M1/127. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).